Quantifying small molecule phenotypic effects using mitochondrial morpho-functional fingerprinting and machine learning
暂无分享,去创建一个
L. Buydens | R. Rodenburg | L. Blanchet | J. Smeitink | J. Beyrath | P. Willems | W. Koopman | A. Jonckheere | C. Vogels | Mina Pellegrini | Sjenet E. van Emst - de Vries
[1] C. Eccleston,et al. Systematic review and meta-analysis of psychological therapies for children with chronic pain. , 2014, Journal of pediatric psychology.
[2] G. Enns. Treatment of Mitochondrial Disorders , 2014, Journal of child neurology.
[3] Aixia Guo,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2014 .
[4] Christoph Sommer,et al. Machine learning in cell biology – teaching computers to recognize phenotypes , 2013, Journal of Cell Science.
[5] J. Smeitink,et al. Primary fibroblasts of NDUFS4(-/-) mice display increased ROS levels and aberrant mitochondrial morphology. , 2013, Mitochondrion.
[6] A. Bast,et al. Ten misconceptions about antioxidants. , 2013, Trends in pharmacological sciences.
[7] D. Cook,et al. A randomized trial of glutamine and antioxidants in critically ill patients. , 2013, The New England journal of medicine.
[8] S. Hecht,et al. Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases. , 2013, Bioorganic & medicinal chemistry.
[9] D. Kerr,et al. Review of Clinical Trials for Mitochondrial Disorders: 1997–2012 , 2013, Neurotherapeutics.
[10] D. Kerr. Review of Clinical Trials for Mitochondrial Disorders: 1997–2012 , 2013, Neurotherapeutics.
[11] Jolein Gloerich,et al. BOLA1 is an aerobic protein that prevents mitochondrial morphology changes induced by glutathione depletion. , 2013, Antioxidants & redox signaling.
[12] T. Ahmad,et al. Computational classification of mitochondrial shapes reflects stress and redox state , 2013, Cell Death and Disease.
[13] D. Breitsprecher,et al. Formins at a glance , 2013, Journal of Cell Science.
[14] J. Smeitink,et al. OXPHOS mutations and neurodegeneration , 2012, The EMBO journal.
[15] R. Rodenburg,et al. Trolox-sensitive reactive oxygen species regulate mitochondrial morphology, oxidative phosphorylation and cytosolic calcium handling in healthy cells. , 2012, Antioxidants & redox signaling.
[16] Vamsi K. Mootha,et al. Mitochondrial disorders as windows into an ancient organelle , 2012, Nature.
[17] E. Bertini,et al. EPI-743 reverses the progression of the pediatric mitochondrial disease--genetically defined Leigh Syndrome. , 2012, Molecular genetics and metabolism.
[18] N. Chandel,et al. Physiological roles of mitochondrial reactive oxygen species. , 2012, Molecular cell.
[19] Lutgarde M. C. Buydens,et al. Interpretation and Visualization of Non-Linear Data Fusion in Kernel Space: Study on Metabolomic Characterization of Progression of Multiple Sclerosis , 2012, PloS one.
[20] B. Halliwell. Free radicals and antioxidants: updating a personal view. , 2012, Nutrition reviews.
[21] Werner J H Koopman,et al. Monogenic mitochondrial disorders. , 2012, The New England journal of medicine.
[22] S. Rahman,et al. Plasma thiol status is altered in children with mitochondrial diseases , 2012, Scandinavian journal of clinical and laboratory investigation.
[23] J. Griffin,et al. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. , 2012, Free radical biology & medicine.
[24] Roland Eils,et al. Multi-Parametric Analysis and Modeling of Relationships between Mitochondrial Morphology and Apoptosis , 2012, PloS one.
[25] P. Reddy,et al. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.
[26] M. Huynen,et al. Restoration of complex V deficiency caused by a novel deletion in the human TMEM70 gene normalizes mitochondrial morphology. , 2011, Mitochondrion.
[27] D. Butterfield,et al. Tuning of the pro-oxidant and antioxidant activity of trolox through the controlled release from biodegradable poly(trolox ester) polymers. , 2011, Journal of biomedical materials research. Part A.
[28] Yi-Hung Huang,et al. Automatic Morphological Subtyping Reveals New Roles of Caspases in Mitochondrial Dynamics , 2011, PLoS Comput. Biol..
[29] J. F. Stevens,et al. Vitamins C and E: beneficial effects from a mechanistic perspective. , 2011, Free radical biology & medicine.
[30] Bryan C Dickinson,et al. Chemistry and biology of reactive oxygen species in signaling or stress responses. , 2011, Nature chemical biology.
[31] R. Rodenburg. Biochemical diagnosis of mitochondrial disorders , 2010, Journal of Inherited Metabolic Disease.
[32] J. Smeitink,et al. Mitochondrial dynamics in human NADH:ubiquinone oxidoreductase deficiency. , 2009, The international journal of biochemistry & cell biology.
[33] C. Nunes,et al. Antioxidant Activity of Vitamin E and Trolox: Understanding of the Factors that Govern Lipid Peroxidation Studies In Vitro , 2009 .
[34] John A. Tallarico,et al. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds , 2009, Nature Reviews Drug Discovery.
[35] J. Smeitink,et al. The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency , 2009, Journal of Molecular Medicine.
[36] R. Brigelius-Flohé. Vitamin E: the shrew waiting to be tamed. , 2009, Free radical biology & medicine.
[37] R. Rodenburg,et al. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. , 2008, Brain : a journal of neurology.
[38] N. Wood,et al. Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts , 2008, Annals of neurology.
[39] J. Smeitink,et al. Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. , 2008, Biochimica et biophysica acta.
[40] R. Rodenburg,et al. NDUFA2 complex I mutation leads to Leigh disease. , 2008, American journal of human genetics.
[41] D. Milea,et al. Modulation of mitochondrial morphology by bioenergetics defects in primary human fibroblasts , 2008, Neuromuscular Disorders.
[42] J. Smeitink,et al. Life cell quantification of mitochondrial membrane potential at the single organelle level , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[43] Stefan Trapp,et al. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[44] J. Smeitink,et al. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. , 2007, Biochimica et biophysica acta.
[45] Christian Gluud,et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. , 2007, JAMA.
[46] V. Petruzzella,et al. Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I* , 2006, Journal of Biological Chemistry.
[47] Lars-Åke Appelqvist,et al. The chemistry and antioxidant properties of tocopherols and tocotrienols , 1996, Lipids.
[48] Werner J H Koopman,et al. Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[49] J. Smeitink,et al. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. , 2005, American journal of physiology. Cell physiology.
[50] F. H. van der Westhuizen,et al. Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. , 2005, American journal of physiology. Cell physiology.
[51] A. Blamire,et al. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. , 2005, Archives of neurology.
[52] Lani F. Wu,et al. Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.
[53] D. Ruppert. The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2004 .
[54] H. Arai,et al. Vitamin E and transfer proteins , 2003, Current opinion in lipidology.
[55] M. Barker,et al. Partial least squares for discrimination , 2003 .
[56] A. Munnich,et al. Molecular insights into Friedreich's ataxia and antioxidant-based therapies. , 2002, Trends in molecular medicine.
[57] A. de Groof,et al. The Creatine Kinase System Is Essential for Optimal Refill of the Sarcoplasmic Reticulum Ca2+ Store in Skeletal Muscle* , 2002, The Journal of Biological Chemistry.
[58] S. Dimauro,et al. The genetics and pathology of oxidative phosphorylation , 2001, Nature Reviews Genetics.
[59] Luhua Lai,et al. A New Atom-Additive Method for Calculating Partition Coefficients , 1997, J. Chem. Inf. Comput. Sci..
[60] J. Concato,et al. A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.
[61] D. R. Parrish,et al. Antioxidant activity and stability of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid , 1975, Journal of the American Oil Chemists' Society.
[62] M. Nishikimi,et al. Oxidation of α-tocopherol model compound by superoxide anion , 1975 .
[63] M. Nishikimi,et al. Oxidation of alpha-tocopherol model compound by superoxide anion. , 1975, Archives of biochemistry and biophysics.
[64] P. Mitchell. Coupling of Phosphorylation to Electron and Hydrogen Transfer by a Chemi-Osmotic type of Mechanism , 1961, Nature.
[65] R. Fisher. THE USE OF MULTIPLE MEASUREMENTS IN TAXONOMIC PROBLEMS , 1936 .